Article de revue
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study
Haemophilus influenzae type b (Hib) conjugate vaccine, delivered as a three-dose series without a booster, was introduced into the childhood vaccination programme in Kenya in 2001. The duration of protection and need for a booster dose are unknown. We aimed to assess vaccine effectiveness, the impact of the vaccine on nasopharyngeal carriage, and population immunity after introduction of conjugate Hib vaccine in infancy without a booster dose in Kenya.
Auteurs
Langues
- Anglais
Année de publication
2016
Journal
The Lancet Global Health
Volume
3
Type
Article de revue
Catégories
- Prestation de services
Maladies
- HIB
Pays
- Kenya
Organisations
- Gavi, l'Alliance du vaccin
Mots-clés
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région africaine